Keyphrases
Chronic Myeloid Leukemia
100%
Induced Apoptosis
100%
Myeloid Leukemia Cells
100%
Imatinib
100%
Sphingosine Kinase 1 (SphK1)
100%
Ceramide
22%
Sphingosine-1-phosphate
22%
Apoptosis
11%
Apoptotic Pathway
11%
Overexpression
11%
Bcl-xL
11%
Primary Cells
11%
Mitochondria
11%
Cytochrome c (Cyt c)
11%
Pharmacological Inhibitors
11%
Small Interfering RNA (siRNA)
11%
Myeloid Cell leukemia-1 (Mcl-1)
11%
Caspase-3 Activation
11%
Resistant Cells
11%
Downstream Effectors
11%
Pro-survival
11%
Cytosine Arabinoside
11%
Leukemia Patients
11%
Sphingolipid Metabolism
11%
Bcl-2 Family
11%
Upstream Regulator
11%
Imatinib Resistance
11%
BCR-ABL
11%
MEK-ERK
11%
ERK Inhibitor
11%
Smac
11%
MEK-ERK Pathway
11%
Farnesyltransferase
11%
Phosphate Balance
11%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Imatinib
100%
Sphingosine Kinase 1
100%
Programmed Cell Death
100%
Ceramide
20%
Sphingosine-1-Phosphate
20%
Cytochrome C
10%
Mitochondrion
10%
Primary Cell
10%
Caspase 3
10%
Small Interfering RNA
10%
Bcl-xL
10%
Bcl-2 Family
10%
Cytarabine
10%
Farnesyltransferase
10%
Sphingolipid Metabolism
10%
Phosphate Balance
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Myeloid Leukemia
100%
Imatinib
100%
Sphingosine Kinase 1
100%
Ceramide
20%
Sphingosine 1 Phosphate
20%
Cytochrome C
10%
Caspase 3
10%
Cytarabine
10%
Small Interfering RNA
10%
Sphingolipid
10%